Cargando…
Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India
BACKGROUND: As a part of a measles and rubella (MR) campaign, the MR vaccine replaced the two-dose measles vaccine at 9–12 months and 16–24 months of age under the Universal Immunization Program (UIP). Although adverse events following immunization (AEFIs) following the measles and MMR vaccine at 9 ...
Autores principales: | Bhowmik, Eshita, Singh, Aaradhana, Sachan, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343355/ https://www.ncbi.nlm.nih.gov/pubmed/32685913 http://dx.doi.org/10.1177/2515135520940131 |
Ejemplares similares
-
Immunogenicity of measles-rubella vaccine administered under India’s Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
por: Verma, Santosh Kumar, et al.
Publicado: (2023) -
Adverse events associated with Measles and Rubella vaccination campaign 2019 in India
por: Sharma, Roop, et al.
Publicado: (2021) -
2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018) -
Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023) -
Cost of conducting Measles-Rubella vaccination campaign in India
por: Chatterjee, Susmita, et al.
Publicado: (2021)